PERCEPTIONS DATA
Sunday, December 18, 2011
Novartis Says Gilenya Showed Positive Clinical Outcomes In Phase III 2309 Study
Novartis Says Gilenya Showed Positive Clinical Outcomes In Phase III 2309 Study
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment